Treatment noncompliance with orally disintegrating olanzapine tablets

被引:7
作者
Freudenreich, O
机构
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2003年 / 48卷 / 05期
关键词
D O I
10.1177/070674370304800521
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:353 / 354
页数:2
相关论文
共 3 条
[1]   Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia [J].
Chue, P ;
Jones, B ;
Taylor, CC ;
Dickson, R .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (08) :771-774
[2]   Determinants of medication compliance in schizophrenia: Empirical and clinical findings [J].
Fenton, WS ;
Blyler, CR ;
Heinssen, RK .
SCHIZOPHRENIA BULLETIN, 1997, 23 (04) :637-651
[3]   Drug-delivery products and the Zydis fast-dissolving dosage form [J].
Seager, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (04) :375-382